GOLDMAN SACHS GROUP INC - IMMUNIC INC ownership

IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 66 filers reported holding IMMUNIC INC in Q2 2023. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IMMUNIC INC
ValueSharesWeighting
Q1 2023$50,021
+11.2%
33,571
+135.4%
0.00%
Q3 2022$45,000
-51.6%
14,263
-47.0%
0.00%
Q2 2022$93,000
-96.7%
26,891
-89.1%
0.00%
-100.0%
Q1 2022$2,781,000
+64.9%
246,121
+39.7%
0.00%
Q4 2021$1,686,000
+13.5%
176,118
+4.9%
0.00%
Q3 2021$1,485,000
+896.6%
167,877
+1283.9%
0.00%
Q2 2021$149,000
-57.2%
12,131
-46.7%
0.00%
Q4 2020$348,000
-13.4%
22,741
+4.9%
0.00%
Q3 2020$402,00021,6690.00%
Other shareholders
IMMUNIC INC shareholders Q2 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 1,788,160$27,341,0004.10%
Parkman Healthcare Partners LLC 366,691$5,607,0001.44%
Altium Capital Management LP 244,155$3,733,0001.39%
Golden Green, Inc. 70,900$1,084,0001.01%
Ghost Tree Capital, LLC 265,000$4,052,0000.90%
Endurant Capital Management LP 138,613$2,119,0000.76%
RTW INVESTMENTS, LP 920,814$14,079,0000.24%
Artal Group S.A. 700,000$10,703,0000.23%
Trexquant Investment LP 17,671$270,0000.03%
Lindbrook Capital, LLC 4,200$64,0000.02%
View complete list of IMMUNIC INC shareholders